Apotex Corp. company information, Employees & Contact Information

Apotex Receives Health Canada Approval for LOQTORZI® — The First and Only Immuno-Therapy for Recurrent Unresectable or Metastatic Nasopharyngeal Cancer Cantech Letter

Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal PR Newswire

Apotex receives Health Canada approval for Aflivu™, a biosimilar to Eylea®, available in pre-filled syringe and vial formats Yahoo! Finance Canada

Apotex publishes 2024 Sustainability Report, highlighting progress and achievements in environmentally sustainable manufacturing, responsible business practices, and social impact PR Newswire Canada

Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment The Malaysian Reserve

Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products Business Wire

Apotex Corp. announces the launch of brimonidine tartrate ophthalmic solution, 0.1% in the United States Ophthalmology Times

Apotex enters the growing Canadian health and wellness sector through the acquisition of CanPrev, a leading Canadian natural health company PR Newswire Canada

Apotex certified as a Great Place To Work in Canada, the U.S., and India PR Newswire

Apotex announces launch of the Apotex Global Health Access Fund to promote health equity with $250,000 in annual funding to the Rexdale Community Health Centre PR Newswire Canada

Apotex acquires US rights to PROVIGIL® (modafinil) and NUVIGIL® (armodafinil) Yahoo Finance

Apotex introduces IVRA™ (Melphalan) hydrochloride injection: First ready to dilute liquid formulation of Melphalan injection approved via 505(b)(2) NDA in the United States PR Newswire

Apotex launches nilotinib capsules, the first generic version of Tasigna®(1) in the United States, with 180 days of exclusivity PR Newswire

Apotex Completes Acquisition of Searchlight, a leading Canadian-based Specialty Innovative Branded Pharmaceutical Company PR Newswire

Apotex Corp. is the first generic manufacturer to launch dasatinib tablets in the United States PR Newswire

Apotex Eye Drops: Uses, Dosage, Side Effects & More Consumer Notice

South Florida drug company recalls 3 eye drugs that might not be sterile Miami Herald

Apotex, through its specialty pharma division, Searchlight, expands branded dermatology portfolio through the in-licensing of the Canadian rights to SEYSARA® (sarecycline) and FINJUVE™ (finasteride) PR Newswire Canada

Apotex Inc. to Present at the 2024 Bloom Burton & Co. Annual Healthcare Investor Conference PR Newswire Canada

Apotex expands ophthalmic franchise through the acquisition of Canadian rights to APP13007 (clobetasol propionate ophthalmic suspension, 0.05%), a novel steroid for ophthalmology PR Newswire Canada

Apotex to Acquire Searchlight Pharma, a Canadian Specialty Branded Pharmaceutical Leader PR Newswire Canada

Apotex Further Expands Oncology Franchise Through the Acquisition of Canadian Rights to Toripalimab PR Newswire Canada

Apotex Corp. recalling nasal sprays due to potential for small glass particles KCBD

SK Capital completes acquisition of Apotex, a global leader in affordable pharmaceuticals PR Newswire Canada

Apotex Corp. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, 28x3 blister pack/carton due to possibility of missing/incorrect tablet arrangement PR Newswire

Apotex Ofloxacin Otic Solution 0.3% Generic Version of Floxin Otic® Now Available PR Newswire

Birth Control Recall After Packaging Error Newsweek

Nasal spray recalled due to glass particles WXYZ Channel 7